期刊文献+

尿激酶型纤溶酶原激活剂基因多态性与血管性痴呆的关系 被引量:1

Association between polymorphism of urokinase-type plasminogen activator gene and vascular dementia
暂未订购
导出
摘要 目的研究尿激酶型纤溶酶原激活剂(PLAU)基因多态性与血管性痴呆(VD)的关系。方法采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法检测132例VD患者(VD组)和121例急性脑梗死患者(对照组)PLAU基因rs2227564位点的多态性,用Logistic回归分析其与VD发病的关系。结果 VD组PLAU基因rs2227564位点C/C基因型53例(40.1%),C/T基因型72例(54.5%),T/T基因型7例(5.4%),C等位基因频率为67.3%,T等位基因频率为32.7%;对照组PLAU基因rs2227564位点C/C基因型39例(32.2%),C/T基因型63例(51.9%),T/T基因型19例(15.9%),C等位基因频率为53.3%,T等位基因频率为46.7%;两组PLAU基因rs2227564位点的基因型和等位基因频率的差异有统计学意义(均P<0.05)。Logistic回归分析显示,PLAU基因rs2227564位点C/C基因型是VD发病的危险因素(OR=1.281,95%CI:1.098~2.577,P=0.037)。结论 PLAU基因多态性与VD的发病相关,PLAU基因rs2227564位点C/C基因型可增加VD患病的风险。 Objective To explore the association between polymorphism of urokinase-type plasminogen activator (PLAU) gene and vascular dementia (VD) . Methods The polymorphism of PLAU gene rs2227564 in 132 VD patients (VD group) and 121 patients with acute cerebral infarction (control group) was examined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP ) technique. The relationship between the polymorphism and the onset of VD was analyzed by Logistic regression. Results In VD group,there were 53 patients (40. 1% ) with C/C genotype of PLAU gene rs2227564,and 72 patients (54. 5% ) with C/T genotype,7 patients (5. 4% ) with T/T genotype; the C allele frequency of PLAU gene rs2227564 was 67. 3% ,and the T allele frequency was 32. 7% . In control group,there were 39 patients (32. 2% ) with C /C genotype of PLAU gene rs2227564,and 63 patients (51. 9% ) with C /T genotype,19 patients (15. 9% ) with T /T genotype; the C allele frequency of PLAU gene rs2227564 was 53. 3% ,and the T allele frequency was 46. 7% . The differences of genotype and allele frequency of PLAU gene rs2227564 between VD group and control group were significant (all P 0. 05) . The Logistic regression analysis showed that the C /C genotype of PLAU gene rs2227564 was the risk factor of the onset of VD (OR = 1. 281,95% CI: 1. 098 - 2. 577,P = 0. 037 ) . Conclusions The PLAU polymorphism is correlated with onset of VD. And the gene C /C genotype of PLAU gene rs2227564 can increase the risk of VD.
出处 《临床神经病学杂志》 CAS 北大核心 2010年第5期326-328,共3页 Journal of Clinical Neurology
关键词 血管性痴呆 尿激酶型纤溶酶原激活剂基因 多态性 vascular dementia urokinase-type plasminogen activator gene polymorphism
  • 相关文献

参考文献11

  • 1Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank [J]. Alzheimer Dis Assoc Disord, 2002, 16: 203.
  • 2Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia [ J ]. J Neurol Neurosurg Psychiatry, 1997, 63 : 749.
  • 3Tucker HM, Kihiko M, Caldwell JN, et al. The plasmin system is induced by and degrades atuyloid-beta aggregates [ J ]. J Neurosci, 2000, 20:3937.
  • 4Li X, Bokman AM, Llinas M, et al. Solution structure of the kringle domain from urokinase-type plasminogen activator[ J]. J Mol Biol, 1994,235 : 1548.
  • 5Yoshimoto M, Ushiyama Y, Sakai M, et al. Characterization of single chain urokinase-type plasminogen activator with a novel aminoacid substitution in the kringle structure [ J ]. Biochim Biophys Acta, 1996, 1293: 83.
  • 6Finckh U, van Hadeln K, Muller-Thomsen T, et al. Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q 22.2 [ J ]. Neurogenetics, 2003,4 : 213.
  • 7Ertekin-Taner N, Ronald J, Feuk L, et al. Elevated amyloid 13 protein (A1342) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene[J].Human Molecular Genetics,2005,14:447.
  • 8季雪莲,贾龙飞,贾建平.尿激酶型纤溶酶原激活剂基因多态性与散发性阿尔茨海默病的相关性[J].中华神经科杂志,2007,40(9):616-617. 被引量:3
  • 9陈伟平,黎锦如,徐书雯,黄飚,高广生,向绍通.脑梗死急性期MRI表现与发展为血管性痴呆的关系[J].临床神经病学杂志,2008,21(1):55-57. 被引量:17
  • 10赵欣春,黄岚.老年性血管性痴呆与脑白质疏松的相关研究[J].临床神经病学杂志,2003,16(4):208-209. 被引量:26

二级参考文献22

  • 1沈天真 陈星荣主编.中枢神经系统CT和MRI 第1版[M].上海医科大学出版社,1992.121.
  • 2Hachinski VC, Potter P, Hevskey H. Leuko-araiosis. Arch Neurol, 1987,44:22.
  • 3Coto K, Ishi N, Tukasaw H. Diffuse white-matter disease in the geriatric population. Radiology, 1984,141 : 687.
  • 4Schelte P, Hijidra AH. Diagnostic criteria for vascular dementia.Haemostasis, 1998,28 : 151.
  • 5David L, Tzer MD, Michael E, et al. Cortical abnormalities associated with subcortial lesions in vascular dementia. Arch Neurol, 1995,52:7.
  • 6MoreUi L, Llovera R, Ibendahl S, et al. The degradation of amyloid beta as a therapeutic strategy in Alzheimer' s disease and cerebrovascular amyloidoses. Neurochem Res, 2002, 27: 1387- 1399.
  • 7Tucker HM, Kihiko M, CaldweU JN, et al. The plasmin system is induced by and degrades amyloid-beta aggregates. J Neurosci, 2000, 20: 3937-3946.
  • 8Finckh U, van Hadeln K, MuUer-Thomsen T, et al. Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22. 2. Neurogenetics, 2003, 4: 213-217.
  • 9Ertekin-Taner N, Ronald J, Feuk L, et al. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer' s disease are associated with single nucleotide polymorphisms in the urokinasetype plasminogen activator gene. Hum Mol Genet, 2005, 14: 447- 460.
  • 10Li X, Bokman AM, Llinas M, et al. Solution structure of the kringle domain from urokinase-type plasminogen activator. J Mol Biol, 1994, 235: 1548-1559.

共引文献43

同被引文献3

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部